Using MLL-AF9 mouse model and a series of leukemia reconstitution experiments in the Alkbh5 conditional knockout mice, we confirmed that Alkbh5 deletion could significantly inhibit the occurrence and development of AML and prolong the survival time of the knockout mice. The gene discussed is ALKBH5; the disease is acute myeloid leukemia.